Have you noticed an increasing number of IVC filter lawsuit commercials airing in your local market? Law firms around the country are launching TV advertising campaigns urging individuals who may have been seriously injured by C.R. Bard Inc.’s retrievable inferior vena cava (IVC) filters to consider taking legal action against the company. Dozens of claims have already been filed over C.R. Bard’s allegedly defective devices, and many more filings are expected in the future.
The nationwide law firm of Bernstein Liebhard LLP has heard from numerous individuals who were allegedly harmed by C.R. Bard Recovery and IVC filters, and our attorneys are currently evaluating cases on behalf of potential claimants. If you suffered complications described in an IVC filter lawsuit advertisement, please contact our office today to learn more about your legal rights.
IVC filters are implanted in the inferior vena cava, where they are able to “catch” blood clots before they can travel to the lungs and become a life-threatening pulmonary embolism. The products at the center of the IVC filter lawsuit commercials now running on TV stations around the country are retrievable, and are intended to be removed once the blood clot danger has passed. A growing number of product liability claims filed over C.R. Bard’s Recovery and G2 devices allege that IVC filters have been linked to hundreds of adverse event reports that detail incidents of inferior vena cava punctures, or cases where filters tilted out of position, migrated or broke apart. When an IVC filter breaks or fractures, metallic fragments may travel to the heart or lungs, a condition known as embolization.
In 2010, the U.S. Food & Drug Administration disclosed that it had received more than 900 reports of complications related to the use of IVC filters. The majority of case – 328 – involved filter migration, while 70 resulted in perforation of the inferior vena cava and 56 were the result of filter fracture. In May 2014, the FDA issued a second alert emphasizing that retrievable IVC filters should be removed within 29 to 54 days after implantation. However, a study published in JAMA: Internal Medicine the previous year suggested that successful retrieval occurred in less than 10% of cases.
In August 2015, IVC filter lawsuits filed against C.R. Bard in federal courts throughout the country were consolidated in a multidistrict litigation now underway in the U.S. District Court, District of Arizona. Twenty-two claims were initially transferred to the proceeding, but legal experts believe that as news of the litigation spreads via IVC filter lawsuit commercials and other media, the number of pending cases will increase.
The attorneys at Bernstein Liebhard LLP are now reviewing cases on behalf of individuals who may have been injured by C.R. Bard’s Recovery and G2 filters. If information presented in an IVC filter lawsuit commercial has you considering legal action, please call our office today at .